An Interest In:
Web News this Week
- March 29, 2024
- March 28, 2024
- March 27, 2024
- March 26, 2024
- March 25, 2024
- March 24, 2024
- March 23, 2024
Some of Our Sources
- Mashable
- Pearsonified
- The Logo Smith
- TutsPlus - Design
- Creative Curio
- Naldz Graphics
- Line 25
- Codrops
- Willems Lab
- Hashedout
Help Webnuz
Referal links:
October 23, 2015 03:23 pm GMT
Turing Pharmaceuticals, a months-old biotech startup thatislargely financed by its 32-year-old founder and CEO Martin Shkreli, sparked widespread outrage last month. The reason: shortly afterpaying $55 million for a 62-year-old drug called Daraprim that’s prescribed for toxoplasmosis and other types of infections, Turing repriced the drug from $13.50 per pill to a stunning $750… Read More
Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/zL4zyMgKPGQ/
A $750 Pill And Its Brash Owner Get Competition And It Costs $1
Turing Pharmaceuticals, a months-old biotech startup thatislargely financed by its 32-year-old founder and CEO Martin Shkreli, sparked widespread outrage last month. The reason: shortly afterpaying $55 million for a 62-year-old drug called Daraprim that’s prescribed for toxoplasmosis and other types of infections, Turing repriced the drug from $13.50 per pill to a stunning $750… Read MoreOriginal Link: http://feedproxy.google.com/~r/Techcrunch/~3/zL4zyMgKPGQ/
Share this article:
Tweet
View Full Article
Techcrunch
TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.More About this Source Visit Techcrunch